Global Endowment Management’s Biogen BIIB Stock Holding History

Global Endowment Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-971	Closed	-$226K	–	105
2019 Q3	$226K	Sell	971 -7,719	-89%	-$1.8M	0.02%	89
2019 Q2	$2.03M	Buy	8,690 +7,600	+697%	+$1.75M	0.2%	38
2019 Q1	$258K	Hold	1,090	–	–	0.04%	200
2018 Q4	$328K	Sell	1,090 -18,990	-95%	-$6.06M	0.07%	122
2018 Q3	$7.09M	Sell	20,080 -2,000	-9%	-$689K	0.94%	17
2018 Q2	$6.41M	Buy	22,080 +5,600	+34%	+$1.57M	0.84%	26
2018 Q1	$4.51M	Buy	16,480 +15,500	+1,582%	+$4.81M	0.65%	22
2017 Q4	$312K	Hold	980	–	–	0.05%	175
2017 Q3	$307K	Sell	980 -12,500	-93%	-$3.7M	0.04%	214
2017 Q2	$3.66M	Buy	13,480 +1,400	+12%	+$370K	0.5%	26
2017 Q1	$3.3M	Buy	12,080 +1,100	+10%	+$311K	0.48%	27
2016 Q4	$3.11M	Buy	10,980 +10,000	+1,020%	+$2.96M	0.48%	24
2016 Q3	$307K	Hold	980	–	–	0.05%	167
2016 Q2	$237K	Hold	980	–	–	0.05%	186
2016 Q1	$255K	Hold	980	–	–	0.05%	180
2015 Q4	$300K	Hold	980	–	–	0.06%	158
2015 Q3	$286K	Buy	+980	New	+$324K	0.04%	191

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Global Endowment Management's BIIB Position: Q4 2019 in Review

Global Endowment Management sold out of Biogen (BIIB) in Q4 2019, closing a stake of 971 shares — an estimated $226K sold.

Global Endowment Management first reported a position in BIIB in Q3 2015 and held it in 17 quarters. The position peaked at $7.09M in Q3 2018. 1,102 funds tracked by Wall St. Rank hold BIIB as of Q4 2019.

Global Endowment Management reported no remaining Biogen position as of Q4 2019 after selling out during the quarter.
Global Endowment Management sold 971 Biogen shares in Q4 2019, an estimated $226K.
Global Endowment Management first reported a position in Biogen in Q3 2015 and held it in 17 quarters.
Global Endowment Management's Biogen position peaked at $7.09M in Q3 2018.
1,102 funds tracked by Wall St. Rank held Biogen as of Q4 2019.

Based on Global Endowment Management's 13F filing for Q4 2019, filed 12 Feb 2020.